Literature DB >> 12083824

In vivo effects of the Epstein-Barr virus small RNA EBER-1 on protein synthesis and cell growth regulation.

Kenneth G Laing1, Androulla Elia, Ian Jeffrey, Volker Matys, Vivienne J Tilleray, Bernard Souberbielle, Michael J Clemens.   

Abstract

Recent studies have suggested a role for the Epstein-Barr virus-encoded RNA EBER-1 in malignant transformation. EBER-1 inhibits the activity of the protein kinase PKR, an inhibitor of protein synthesis with tumour suppressor properties. In human 293 cells and murine embryonic fibroblasts, transient expression of EBER-1 promoted total protein synthesis and enhanced the expression of cotransfected reporter genes. However reporter gene expression was stimulated equally well in cells from control and PKR knockout mice. NIH 3T3 cells stably expressing EBER-1 exhibited a greatly increased frequency of colony formation in soft agar, and protein synthesis in these cells was relatively resistant to inhibition by the calcium ionophore A23187. Nevertheless clones containing a high concentration of EBER-1 were not invariably tumourigenic. We conclude that EBER-1 can enhance protein synthesis by a PKR-independent mechanism and that, although this RNA may contribute to the oncogenic potential of Epstein-Barr virus, its expression is not always sufficient for malignant transformation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12083824     DOI: 10.1006/viro.2002.1354

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  12 in total

1.  Inhibition of the protein kinase PKR by the internal ribosome entry site of hepatitis C virus genomic RNA.

Authors:  Jashmin Vyas; Androulla Elia; Michael J Clemens
Journal:  RNA       Date:  2003-07       Impact factor: 4.942

2.  Lymphoid hyperplasia and lymphoma in transgenic mice expressing the small non-coding RNA, EBER1 of Epstein-Barr virus.

Authors:  Claire E Repellin; Penelope M Tsimbouri; Adrian W Philbey; Joanna B Wilson
Journal:  PLoS One       Date:  2010-02-08       Impact factor: 3.240

3.  Epstein-Barr virus-encoded EBNA1 enhances RNA polymerase III-dependent EBER expression through induction of EBER-associated cellular transcription factors.

Authors:  Thomas J Owen; John D O'Neil; Christopher W Dawson; Chunfang Hu; Xiaoyi Chen; Yunhong Yao; Victoria H J Wood; Louise E Mitchell; Robert J White; Lawrence S Young; John R Arrand
Journal:  Mol Cancer       Date:  2010-09-15       Impact factor: 27.401

4.  Growth-promoting properties of Epstein-Barr virus EBER-1 RNA correlate with ribosomal protein L22 binding.

Authors:  Jennifer L Houmani; Christopher I Davis; Ingrid K Ruf
Journal:  J Virol       Date:  2009-07-29       Impact factor: 5.103

5.  Adenosine deaminase ADAR1 increases gene expression at the translational level by decreasing protein kinase PKR-dependent eIF-2alpha phosphorylation.

Authors:  Ying Wang; Charles E Samuel
Journal:  J Mol Biol       Date:  2009-09-03       Impact factor: 5.469

6.  A phylogenetically conserved RNA structure in the poliovirus open reading frame inhibits the antiviral endoribonuclease RNase L.

Authors:  Jian-Qiu Han; Hannah L Townsend; Babal Kant Jha; Jayashree M Paranjape; Robert H Silverman; David J Barton
Journal:  J Virol       Date:  2007-03-07       Impact factor: 5.103

Review 7.  Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action.

Authors:  M A García; J Gil; I Ventoso; S Guerra; E Domingo; C Rivas; M Esteban
Journal:  Microbiol Mol Biol Rev       Date:  2006-12       Impact factor: 11.056

8.  Epstein-Barr virus-encoded RNAs (EBERs) complement the loss of Herpesvirus telomerase RNA (vTR) in virus-induced tumor formation.

Authors:  Ahmed Kheimar; Benedikt B Kaufer
Journal:  Sci Rep       Date:  2018-01-09       Impact factor: 4.379

Review 9.  Viral lncRNA: A regulatory molecule for controlling virus life cycle.

Authors:  Ziqiang Wang; Yiwan Zhao; Yaou Zhang
Journal:  Noncoding RNA Res       Date:  2017-03-23

10.  Epstein-Barr virus-encoded small RNAs (EBERs) are present in fractions related to exosomes released by EBV-transformed cells.

Authors:  Waqar Ahmed; Pretty S Philip; Saeed Tariq; Gulfaraz Khan
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.